AARDEX Group
AARDEX Group provides cloud-based medication adherence software (MEMS AS) and connected packaging/devices for clinical trials, helping pharmaceutical companies, biotech firms and CROs monitor dosing behavior in real time across oral, injectable and inhaled routes.
- Company typePrivate
- Founded1984
- HeadquartersSeraing, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What AARDEX Group does
AARDEX Group is a privately held Swiss-headquartered company that provides data-driven medication adherence solutions for clinical trials. Founded in 1984 (firmographics note: 1987) and operating from Sion, Seraing and Boulder, it serves pharmaceutical companies, biotech firms and contract research organizations that need objective, real-time visibility into how trial participants take investigational medicines. Non-adherence is reported to affect up to half of trial participants and undermines the statistical power, regulatory credibility and cost profile of drug development programs.
The company's core asset is the MEMS AS cloud platform, which processes timestamped dosing events captured by a portfolio of smart packaging, dispensers, pen-injector add-ons and an FDA 510(k)-cleared ingestible sensor. More than 70 proprietary algorithms convert that data into dashboards, Key Risk Indicators and ranked lists of participants requiring coaching. The participant-facing MEMS Mobile app is available in 25 languages and across 30 countries, and the system is positioned against ICH E6(R3), HIPAA, GDPR and ISO 27001 standards. Hardware and software are complemented by a professional services team led by Scientific Lead Bernard Vrijens.
AARDEX monetizes through a mix of enterprise software subscriptions for MEMS AS, hardware sales of adherence packaging and devices (much of it sourced from technology partners such as Westrock, Schreiner MediPharm, etecRx, Mevia, Biocorp, medmix, Pill Connect, CMT and OnDosis), and professional services supporting RBQM-aligned adherence strategy. Pricing is quote-based and contracted on multi-year enterprise terms with pharmaceutical sponsors and CROs, with no public list pricing disclosed.
AARDEX Group firmographics
Firmographics- Name
- AARDEX Group
- Legal name
- AARDEX Group
- Website
- https://aardexgroup.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AARDEX Group provides cloud-based medication adherence software (MEMS AS) and connected packaging/devices for clinical trials, helping pharmaceutical companies, biotech firms and CROs monitor dosing behavior in real time across oral, injectable and inhaled routes.
- Ownership category
- akta.pro rank
AARDEX Group industry classification
Industry- Product category
- Clinical Trial Adherence Software
- NAICS
- Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
- akta.pro secondary industries
- Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ), Medication Safety, Pharmacovigilance & Adverse Event Reporting IT (HLACAKAK)
Keywords
Where AARDEX Group is headquartered
LocationHeadquarters
- HQ city
- Seraing
- HQ country
- Belgium
- HQ region
- Europe
Offices3 records
Markets served
AARDEX Group business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- MEMS AS Software Subscription: Cloud-based medication adherence software provided as subscription service to pharmaceutical companies and CROs conducting clinical trials. Powers real-time monitoring and analytics for adherence data.
- Hardware Sales (Adherence Packaging and Devices): Sale of digitally-enabled medication adherence packaging (MEMS Cap, CleverCap Lite, Pill Connect, Dosepak, Cerepak, Smart Blister Pack, Injectapak) and devices (Mallya, Injay, D-Flex Logbook, OnDosis Dosage Manager). Includes both one-time device sales and ongoing consumables.
- Professional Services: AARDEX Professional Services Team supports sponsors and CROs in implementing MEMS AS and designing adherence strategies aligned with Risk-Based Quality Management (RBQM). Includes consultation with adherence expert Bernard Vrijens.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise B2B pricing for pharmaceutical companies |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
AARDEX Group product offering
Product offeringCore offering
AARDEX Group provides a medication adherence ecosystem for clinical trials centered on its cloud-based MEMS AS software platform. The platform ingests real-time medication event data from a network of digitally-enabled smart packaging, electronic pills, and monitoring devices, then applies 70+ proprietary algorithms to detect non-adherence patterns such as missed doses, drug holidays, and overdoses. The offering is sold to pharmaceutical sponsors, biotech firms, and contract research organizations to safeguard trial data integrity and meet ICH E6(R3) Risk-Based Quality Management expectations.
Product overview
AARDEX Group offers a comprehensive medication adherence ecosystem for clinical trials built around its core MEMS AS platform. The ecosystem integrates smart medication adherence packaging (MEMS Cap, CleverCap Lite, Pill Connect, Electronic Dosepak, Cerepak, Smart Blister Wallet, MEMS HH, Injectapak), electronic pills (ID-Cap), and adherence monitoring devices (MEMS Button, Mallya, Injay, D-Flex Logbook, OnDosis Dosage Manager, Medose, Mepill), all synchronized with MEMS AS software for real-time adherence analytics. A participant-facing companion app, MEMS Mobile, provides medication reminders and surveys. The platform supports all routes of drug administration (oral, injectable, inhalable, topical) and is backed by FDA, ICH GCP, HIPAA, GDPR, and ISO 27001 compliance.
Differentiator
Problem solved
Functional benefit
Brands
- MEMS AS: Cloud-based medication adherence software platform powered by over 70 proprietary algorithms for real-time monitoring and analytics in clinical trials.
- MEMS Mobile
- MEMS Cap
- MEMS Button
- MEMS HH (Helping Hand)
- Cerepak
- Dosepak
- ID-Cap
- Injectapak
- CleverCap Lite
- Pill Connect
- Smart Blister Pack
- Medose
- Mepill
- Mallya
- Injay
- D-Flex Logbook
- OnDosis Dosage Manager
Products and services
- MEMS AS Medication Adherence Software Secure, cloud-based medication adherence software platform that processes real-time medication event data from digitally-enabled packaging and devices using 70+ proprietary algorithms to detect missed doses, drug holidays, and overdoses, providing real-time dashboards, Key Risk Indicators, Central Statistical Monitoring, and patient profile visualizations for clinical trial investigators.
- MEMS Mobile App Participant-facing mobile medication adherence app providing customizable reminders, medication scheduling, dosing history, and in-app surveys. Syncs with MEMS AS to provide researchers with adherence data while helping participants stay on track with dosing regimens.
- MEMS Cap Smart Pill Bottle Intelligent track cap with hidden sensors that transforms standard pill bottles into smart pill bottles by recording the date and time of each medication intake, with optional LCD screen, 36-month battery life, and water resistance; CE marked.
- MEMS Helping Hand (MEMS HH) Reusable plastic sleeve with integrated microcircuit technology that records the date and time when a blister pack is removed; CE marked with wireless data transfer capability.
- MEMS Button Electronic medication event monitoring system with a micro-electronic circuit that records the date and time each time the participant presses the button to take medication; CE marked and compatible with most medication packages.
Quantifiable outcome
- 97% accuracy in tracking medication events vs 70% (PK sampling), 60% (pill count), 27% (self-report)
- +3 more outcomes
Companies that use AARDEX Group
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
AARDEX Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature6 records
AARDEX Group partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- WestrockcoreWestrock provides Electronic Dosepak (EDP), Cerepak, and Injectapak medication adherence packaging solutions integrated with AARDEX Group's MEMS AS software. Westrock's packaging features hidden sensors/microprocessors that capture medication event data for analysis in MEMS AS dashboards.
- Schreiner MediPharmcoreSchreiner MediPharm provides Smart Blister Pack with concealed trackers in every cavity that capture exact time and date when medication is removed. Data synchronizes with MEMS AS for real-time compliance monitoring in clinical trials.
- Pill ConnectcorePill Connect provides smart pill dispenser with advanced features that dispenses the right dose at the right time. Hidden sensors capture date and time pills are dispensed, with data analyzed via MEMS AS using over 70 proprietary algorithms.
- CMTcoreCMT provides CleverCap Lite digital pill dispenser that harnesses light and sound alerts to remind trial participants to take medications on time. Integrated with MEMS AS for real-time adherence statistics.
- etecRxcoreetecRx provides ID-Cap electronic pill system with ingestible wireless sensor (ID-Tag) that transmits medication event data to wearable device. FDA 510(k) cleared in 2019 with 98% user engagement rate. Data accessed via MEMS AS.
- MeviacoreMevia provides Medose and Mepill - cellular medication event monitoring devices that detect pill extraction in real-time. Sustainable smart packaging with no single-use electronics. Data integrates via Mevia's APIs.
- BiocorpcoreBiocorp provides Mallya (self-injection pen add-on) and Injay (pre-filled syringe add-on) that automatically capture date and time of injections. Integration enables automated injection event data collection for MEMS AS.
- medmixcoremedmix provides D-Flex Logbook pen injector add-on that automatically captures date and time of injections. Replaces standard cap with sensor-equipped cap that stores injection data.
- OnDosiscoreOnDosis provides Dosage Manager - an innovative medication delivery and management solution for clinical trial patients. Integrated with MEMS AS for comprehensive adherence monitoring.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
AARDEX Group competitors and assessment
Company assessmentOthers
- West Pharmaceutical Services: West (formerly Westrock) is a primary AARDEX packaging partner and an integral part of the MEMS AS ecosystem via Dosepak, Cerepak, and Injectapak. It is an ecosystem participant rather than a direct competitor, but could internalize adherence analytics over time.
Emerging players
- Curebase: Curebase provides a decentralized clinical trial platform with eConsent, eCOA, telehealth, and remote patient monitoring. It intersects with AARDEX in the patient-side trial technology layer where adherence is captured and reported.
- YPrime: YPrime provides eCOA, IRT, and clinical technology with a focus on mobile-first and decentralized trials. It overlaps with AARDEX in patient-facing trial technology and serves the same mid-market and enterprise sponsor segment.
- ObvioHealth: ObvioHealth runs fully decentralized clinical trials with its own app-based patient engagement, eCOA, and adherence tools. It targets the same decentralized-trial opportunity AARDEX addresses and is a viable alternative for sponsors.
Direct peers
- Clario: Clario delivers eCOA, cardiac safety, and imaging solutions for clinical trials with adjacent adherence and patient engagement tooling. It competes for the same pharma/CRO procurement budgets and increasingly bundles adherence into broader decentralized trial offerings.
- AiCure: AiCure uses AI-driven facial recognition and computer vision on patient smartphones to confirm medication ingestion in clinical trials. It is a direct adherence-measurement competitor using a different technological approach (vision-based vs. packaging/cap-based).
- Signant Health: Signant Health (formerly CRF Health and Bracket) provides eCOA, ePRO, and patient engagement solutions for clinical trials, including adherence and dosing reminders. It directly overlaps AARDEX in trial-level adherence measurement and serves the same sponsor and CRO buyer base.
Broad incumbents
- IQVIA: IQVIA combines CRO services with its own eClinical technology platform (Orchestrated Patient Engagement, EDC, RTSM). It is both a potential AARDEX buyer/customer (via its CRO arm) and a competitor (via in-house clinical tech).
- Veeva Systems: Veeva offers Vault CTMS, EDC, ePRO, and clinical operations suites. While not focused on adherence specifically, Veeva is a dominant enterprise eClinical vendor that increasingly targets decentralized trial workflows where AARDEX plays.
- Medidata Solutions: Medidata (a Dassault Systèmes company) provides a broad eClinical platform including EDC, IRT, eCOA, and CTMS. As a broad incumbent, it competes by bundling trial-level capabilities and could absorb adherence functionality into its unified Rave platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
AARDEX Group social profiles
Digital presenceAARDEX Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
AARDEX Group leadership team
Management profileNumber of profiles
Profiles1 record
AARDEX Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AARDEX Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AARDEX Group
What does AARDEX Group do?
AARDEX Group provides a medication adherence ecosystem for clinical trials centered on its cloud-based MEMS AS software platform. The platform ingests real-time medication event data from a network of digitally-enabled smart packaging, electronic pills, and monitoring devices, then applies 70+ proprietary algorithms to detect non-adherence patterns such as missed doses, drug holidays, and overdoses. The offering is sold to pharmaceutical sponsors, biotech firms, and contract research organizations to safeguard trial data integrity and meet ICH E6(R3) Risk-Based Quality Management expectations.
Is AARDEX Group a public or private company?
AARDEX Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AARDEX Group founded?
AARDEX Group was founded in 1984. It employs 11 to 50 people.
Where is AARDEX Group based?
AARDEX Group is headquartered in Seraing, Belgium, in the Europe region.
How does AARDEX Group make money?
Three revenue lines are on record. MEMS AS Software Subscription is the primary driver. The others are hardware Sales (Adherence Packaging and Devices) and professional Services.
Who are AARDEX Group's main competitors?
West Pharmaceutical Services is listed as an others. Emerging players are Curebase, YPrime and ObvioHealth. Direct peers are Clario, AiCure and Signant Health. Broad incumbents are IQVIA, Veeva Systems and Medidata Solutions.
Does AARDEX Group have an API?
No public API is recorded for AARDEX Group.
What industry is AARDEX Group in?
AARDEX Group's product category is Clinical Trial Adherence Software. Its primary akta.pro industry code is HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM), with a secondary code of HLAFALAJ, Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose). Its NAICS code is 541690 and its SIC code is 7372.